Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
about
Blood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyOpposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.Meditation and vacation effects have an impact on disease-associated molecular phenotypes.Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data.Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid.Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals.Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer's disease diagnosis and prognosis.Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.Plasma amyloid beta peptides: an Alzheimer's conundrum or a more accessible Alzheimer's biomarker?Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.Plasma Amyloid Is Associated with White Matter and Subcortical Alterations and Is Modulated by Age and Seasonal Rhythms in Mouse Lemur Primates.Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial.Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.Aging and are determinative factors of plasma A42 levels
P2860
Q26774743-316C8CFF-2349-4C1B-8AC8-18B90011606CQ30703354-0250EC95-1620-4604-A824-E5DBD17613CAQ34482760-155AC4D5-035A-44F0-B3B0-9E10AF52317CQ34538942-2E0D1284-1121-4510-8438-C30CCFC775BFQ37300264-4C0CDCDD-3EAA-402F-A359-9B5E8554ACFFQ37346081-3F82DC95-DBB1-4DF4-A3D6-6D34F8A85451Q38666998-FDDF3BCD-6BC1-4D88-8EEC-F33B5461926AQ38672291-4B7C00D9-E53E-47F3-AF86-00040D5BB71EQ38680904-EA7DA4E5-D212-4955-BAAB-6897D908A1F5Q39217840-106C2583-71CF-4B31-BFA8-99FC678C5A4CQ41690745-75404FAF-8CB9-414D-849B-2AB2ABBBD780Q41845239-B8755E66-6868-4D94-8111-D1DD649BF6C3Q46240783-8C926751-8038-48CE-ACF0-2A96354A5587Q48031219-72342308-8EFD-4CDE-938B-7F3FF25522F1Q48605183-5622AA6C-E4A7-4E77-A2F5-C2A1F0FCE42BQ49135523-97E0FD7E-D9C1-44F6-8987-8095B4E77614Q50354591-81A76F23-6436-4677-9E64-0F02E3139EAAQ52142977-2429E63E-5909-46F5-A1D8-309212CCFE39Q52148328-BD714528-8689-4811-A450-45EA05D97DCBQ55516241-26C02E4F-1CAF-42C9-9794-9A05CB12A1BCQ57822409-1E22B602-A161-4419-8CF7-67B911269EEC
P2860
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@ast
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@en
type
label
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@ast
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@en
prefLabel
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@ast
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@en
P2093
P2860
P50
P1476
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
@en
P2093
Galit Weinstein
Ingmar Skoog
Linda Younkin
Philip A Wolf
Sarah Rosner Preis
Steven Younkin
Vincent Chouraki
P2860
P304
P356
10.1016/J.JALZ.2014.07.001
P577
2014-09-10T00:00:00Z